A machine learning model for skin disease classification using convolution neural network

Abstract

Melanoma is a skin disease that tends to be lethal. It occurs when melanocytes develop in an uncontrolled manner. Melanoma goes under a few different names, including malignant melanoma. The incidence of melanoma is at its highest level ever recorded in both Australia and New Zealand. It is estimated that one in every 15 white New Zealanders will indeed be diagnosed with melanoma at some point in their lives. Aggressive malignancy was the third most common kind of cancer in men and women in 2012, respectively. Melanoma can develop at any age in adults, but it is highly unusual in children and teenagers. It is hypothesized that the first step in developing melanoma is an unregulated multiplication of melanocytic stem cells that have been genetically altered. The survival rate can significantly increase if melanoma is identified in dermos copy images at an earlier stage. On the other hand, the detection of melanomas is an incredibly challenging task. Consequently, the detection and recognition of skin cancer are of tremendous assistance to the accuracy of pathologists. In this research, a deep learning technique is shown for reliably diagnosing the type of melanoma present at a preliminary phase. The proposed model makes a distinction among lesion maligna, superficial spreading, and nodular melanoma. This permits the early diagnosis of the virus and the quick isolation and therapy necessary to stop the transmission of infection further. Deep learning (DL) and the standard non-parametric machine learning method are exemplified in the deep layer topologies of the convolutional neural network (CNN), which are neural network algorithms. The effectiveness of a CNN classifier was evaluated using data retrieved from the website https://dermnetnz.org/. The outcomes of the experiments show that the proposed method is superior in terms of diagnostic accuracy compared to the methodologies that are currently considered state of the art.